  | Guiot, J., André, B., Potjewijd, J., JACQUERIE, P., Cremers, S., Henket, M., Idoufkir, L., Remacle, C., Tobal, R., GILTAY, L., Moermans, C., GESTER, F., Polese, B., Hamaïdia, M., Struman, I., Louis, E., Malaise, M., de Seny, D., van Paassen, P., ... Njock, M.-S. (2025). Association of fibrotic-related extracellular vesicle microRNAs with lung involvement in systemic sclerosis. European Respiratory Journal, 2400276. doi:10.1183/13993003.00276-2024  Peer Reviewed verified by ORBi |
 | Schleich, F., ZIANT, S., LOUIS, S., Moermans, C., DEROISY, R., Louis, R., Kaux, J.-F., & Bury, T. (December 2024). Uncontrolled asthma is Associated with Increased Visceral Adipose Tissue, Decreased Bone Mineral Content, and Reduced Exercise Capacity. Journal of Asthma and Allergy, 17, 1369-1382. doi:10.2147/JAA.S474667 Peer Reviewed verified by ORBi |
 | Graff, S., Moermans, C., Gerday, S., Henket, M., PAULUS, V., GUISSARD, F., Louis, R., & Schleich, F. (30 November 2024). Increase in Blood Eosinophil Count Over Time and Sputum IL8 are Associated with FEV1 Decline in Asthma. Lung, 203 (1), 8. doi:10.1007/s00408-024-00760-9 Peer Reviewed verified by ORBi |
 | Bonhiver, R., Bricmont, N., Pirotte, M., Wuidart, M.-A., Monseur, J., Benchimol, L., Poirrier, A.-L., Moermans, C., CALMES, D., Schleich, F., Louis, R., Seghaye, M.-C., & Kempeneers, C. (2024). Evidence for secondary ciliary dyskinesia in patients with cystic fibrosis. Journal of Cystic Fibrosis. doi:10.1016/j.jcf.2024.10.003 Peer Reviewed verified by ORBi |
 | Schleich, F., SABBE, M., Moermans, C., & Louis, R. (January 2024). Le médicament du mois. Tézépélumab (Tezspire®) : nouveau traitement biologique de l’asthme sévère. Revue Médicale de Liège, 79 (1), 60 - 64. Editorial Reviewed verified by ORBi |
 | Schleich, F., Moermans, C., Seidel, L., Kempeneers, C., Louis, G., ROGISTER, F., Tombu, S., Pottier, L., Poirrier, A.-L., ZIANT, S., Henket, M., SANCHEZ, C., PAULUS, V., GUISSARD, F., Donneau, A.-F., & Louis, R. (November 2023). Benralizumab in severe eosinophilic asthma in real life: confirmed effectiveness and contrasted effect on sputum eosinophilia versus exhaled nitric oxide fraction - PROMISE. ERJ Open Research, 9 (6). doi:10.1183/23120541.00383-2023 Peer Reviewed verified by ORBi Dataset: 10.1183/23120541.00383-2023 |
 | Schleich, F., Moermans, C., Gerday, S., ZIANT, S., Louis, G., Bougard, N., PAULUS, V., GUISSARD, F., Henket, M., Bachert, C., & Louis, R. (October 2023). Patients With Asthma Only Sensitized to Staphylococcus aureus Enterotoxins Have More Exacerbations, Airflow Limitation, and Higher Levels of Sputum IL-5 and IgE. Journal of Allergy and Clinical Immunology: In Practice, 11 (10), 3055-3061.e4. doi:10.1016/j.jaip.2023.05.043 Peer Reviewed verified by ORBi Dataset: 10.1016/j.jaip.2023.05.043 |
 | Bricmont, N., Bonhiver, R., Benchimol, L., Louis, B., Papon, J.-F., Monseur, J., Donneau, A.-F., Moermans, C., Schleich, F., CALMES, D., Poirrier, A.-L., Louis, R., Seghaye, M.-C., & Kempeneers, C. (18 September 2023). Temporal Stability of Ciliary Beating Post Nasal Brushing, Modulated by Storage Temperature. Diagnostics, 13 (18), 2974. doi:10.3390/diagnostics13182974 Peer reviewed |
 | Sabbe, M., Schleich, F., Bougard, N., Moermans, C., Henquet, M., GUISSARD, F., Sanschez, C., PAULUS, V., & Louis, R. (2023). Sputum cell counts and FeNO levels in patients treated with anti-IgE and anti-IL-5 /IL-5R: Evidence for a dissociation between sputum eosinophil counts and FeNO levels. European Respiratory Journal 62(suppl 67): PA989 Published: Sep 2023, 989. doi:10.1183/13993003.congress-2023.pa989 Peer reviewed |
 | Gerday, S., Graff, S., Moermans, C., GUISSARD, F., PAULUS, V., Henket, M., Louis, R., & Schleich, F. (2023). Super-responders to anti-IL-5/anti-IL-5R are characterised by high sputum eosinophil counts at baseline. Thorax, 2022-219781. doi:10.1136/thorax-2022-219781 Peer Reviewed verified by ORBi |
 | Kempeneers, C., Bonhiver, R., Bricmont, N., Pirotte, M., Engelskirchen, S., Benchimol, L., CALMES, D., GUISSARD, F., Moermans, C., Seghaye, M.-C., Louis, R., & Schleich, F. (September 2023). Ciliary dyskinesia in severe asthma is not affected by chronic mucus hypersecretion. ERJ Open Research, 9 (5). doi:10.1183/23120541.00220-2023 Peer Reviewed verified by ORBi Dataset: 10.1183/23120541.00220-2023 |
 | Zahraei, H. N., Schleich, F., Gerday, S., GUISSARD, F., PAULUS, V., Henket, M., Moermans, C., Donneau, A.-F.* , & Louis, R.*. (June 2023). A clustering analysis of eosinophilic asthmatics: Two clusters with sharp differences in atopic status and disease severity. Clinical and Experimental Allergy, 53 (6), 672-678. doi:10.1111/cea.14312 Peer reviewed Dataset: 10.1111/cea.14312* These authors have contributed equally to this work. |
 | Guiot, J., Henket, M., Remacle, C., Cambier, M., Struman, I., Winandy, M.-L., Moermans, C., Louis, E., Malaise, M., Ribbens, C., Louis, R., & Njock, M.-S. (15 April 2023). Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis. Respiratory Research, 24 (1), 112. doi:10.1186/s12931-023-02413-6 Peer Reviewed verified by ORBi |
 | Schleich, F., Bougard, N., Moermans, C., Sabbe, M., & Louis, R. (April 2023). Cytokine-targeted therapies for asthma and COPD. European Respiratory Review: an Official Journal of the European Respiratory Society, 32 (168). doi:10.1183/16000617.0193-2022 Peer reviewed Dataset: 10.1183/16000617.0193-2022 |
 | Moermans, C., Brion, C., BOCK, G., Graff, S., Gerday, S., Nekoee, H., Poulet, C., Bricmont, N., Henket, M., PAULUS, V., GUISSARD, F., Louis, R., & Schleich, F. (2023). Sputum Type 2 Markers Could Predict Remission in Severe Asthma Treated With Anti-IL-5. CHEST. doi:10.1016/j.chest.2023.01.037 Peer Reviewed verified by ORBi |
 | Kempeneers, C., Bonhiver, R., Bricmont, N., Pirotte, M., GUISSARD, F., Moermans, C., Seghaye, M.-C., Louis, R., & Schleich, F. (04 September 2022). A primary ciliary dysfunction might be present in severe asthma [Paper presentation]. ERS International Congress, Barcelone, Spain. Peer reviewed |
KEMPENEERS, C., Bricmont, N., Bonhiver, R., Pirotte, M., GUISSARD, F., MOERMANS, C., SEGHAYE, M.-C., LOUIS, R., & SCHLEICH, F. (18 May 2022). Ciliary dyskinesia is increased in severe asthma, but is not affected by chronic mucus hypersecretion [Poster presentation]. Congress of American Thoracic Society, San Francisco, United States - California. Peer reviewed |
 | Schleich, F., Graff, S., Bougard, N., Frix, A.-N., Peerboom, S., Demarche, S., GUISSARD, F., PAULUS, V., Henket, M., CALMES, D., Moermans, C., & Louis, R. (May 2022). L’asthme bronchique en pratique clinique : des phénotypes inflammatoires au traitement personnalisé. Revue Médicale de Liège, 77 (5-6), 289-294. Editorial Reviewed verified by ORBi |
 | Corhay, J.-L., Bonhomme, O., HEINEN, V., Moermans, C., & Louis, R. (May 2022). La bronchopneumopathie chronique obstructive. Une maladie inflammatoire chronique. Revue Médicale de Liège, 77 (5-6), 295-301. Editorial Reviewed verified by ORBi |
 | GUIOT, J., HENKET, M., Frix, A.-N., GESTER, F., THYS, M., GILTAY, L., DESIR, C., MOERMANS, C., NJOCK, M.-S., MEUNIER, P., CORHAY, J.-L., & LOUIS, R. (11 April 2022). Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ? Respiratory Research, 23 (1), 89. doi:10.1186/s12931-022-02006-9 Peer Reviewed verified by ORBi |
 | Moermans, C., Graff, S., Gerday, S., Schleich, F., Guiot, J., Njock, M.-S., & Louis, R. (2022). LES PROBIOTIQUES DANS LE TRAITEMENT DE L’ASTHME. Revue Médicale de Liège, 77 (5-6), 285 - 288. Editorial Reviewed verified by ORBi |
Bonhiver, R., Bricmont, N., Pirotte, M., MOERMANS, C., Wuidart, M.-A., Pirson, J., Louis, R., SEGHAYE, M.-C., KEMPENEERS, C., & BOBOLI, H. (September 2021). Evidence for ciliary dyskinesia in cystic fibrosis [Paper presentation]. European Respiratory Congress. |
Bricmont, N., Bonhiver, R., Benchimol, L., Pirotte, M., MOERMANS, C., POIRRIER, A.-L., LEFEBVRE, P., LOUIS, R., SEGHAYE, M.-C., & KEMPENEERS, C. (September 2021). Ciliary videomicroscopy at room temperature might lack sensitivity for primary ciliary dyskinesia diagnosis [Poster presentation]. European Respiratory Society (ERS). |
 | JACQUERIE, P., HENKET, M., André, B., MOERMANS, C., DE SENY, D., GESTER, F., LOUIS, R., MALAISE, M., & GUIOT, J. (21 May 2021). Inflammatory profile of induced sputum composition in systemic sclerosis and comparison with healthy volunteers. Scientific Reports, 11 (1), 10679. doi:10.1038/s41598-021-87701-1 Peer Reviewed verified by ORBi |
 | Moermans, C., Damas, K., Guiot, J., NJOCK, M.-S., Corhay, J.-L., Henket, M., Schleich, F., & Louis, R. (April 2021). Sputum IL-25, IL-33 and TSLP, IL-23 and IL-36 in airway obstructive diseases. Reduced levels of IL-36 in eosinophilic phenotype. Cytokine, 140, 155421. doi:10.1016/j.cyto.2021.155421 Peer Reviewed verified by ORBi |
 | Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x Peer Reviewed verified by ORBi |
 | Calmes, D., Huynen, P., Paulus, V., Henket, M., Guissard, F., Moermans, C., Louis, R., & Schleich, F. (2021). Chronic infection with Chlamydia pneumoniae in asthma: a type-2 low infection related phenotype. Respiratory Research, 22 (1), 72. doi:10.1186/s12931-021-01635-w Peer Reviewed verified by ORBi |
 | GUIOT, J., NJOCK, M.-S., ANDRE, B., GESTER, F., HENKET, M., DE SENY, D., MOERMANS, C., MALAISE, M., & LOUIS, R. (2021). Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction. Scientific Reports, 11 (1), 10882. doi:10.1038/s41598-021-90333-0 Peer Reviewed verified by ORBi |
 | Parzibut, G., Henket, M., Moermans, C., Struman, I., Louis, E., Malaise, M., Louis, R., Misset, B., NJOCK, M.-S.* , & Guiot, J.*. (2021). A Blood Exosomal miRNA Signature in Acute Respiratory Distress Syndrome. Frontiers in Molecular Biosciences, 8, 640042. doi:10.3389/fmolb.2021.640042 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Guiot, J., HENKET, M., NJOCK, M.-S., MOERMANS, C., Struman, I., Corhay, J.-L., & Louis, R. (2021). La fibrose pulmonaire : des biomarqueurs à de nouveaux horizons thérapeutiques. Revue Médicale de Liège, 76 (3), 166-172. Peer reviewed |
 | Graff, S., Zanella, D., Stefanuto, P.-H., HENKET, M., PAULUS, V., GUISSARD, F., MOERMANS, C., Van Steen, K., Louis, R., & Schleich, F. (2021). Are Volatile Organic Compounds Able to Identify Airflow Decline in Asthma? Journal of Asthma and Allergy, 14, 67-70. doi:10.2147/JAA.S289278 Peer Reviewed verified by ORBi |
 | Graff, S., Bricmont, N., MOERMANS, C., HENKET, M., PAULUS, V., GUISSARD, F., LOUIS, R., & SCHLEICH, F. (2020). Clinical and biological factors associated with irreversible airway obstruction in adult asthma. Respiratory Medicine. doi:10.1016/j.rmed.2020.106202 Peer Reviewed verified by ORBi |
Parzibut, G., GUIOT, J., Misset, B., MALAISE, M., LOUIS, R., LOUIS, E., HENKET, M., MOERMANS, C., & NJOCK, M.-S. (September 2020). Alteration of Plasma Exosome Content in Acute Respiratory Distress Syndrome: a miRNA signature associated to lung fibrosing process [Poster presentation]. ERS International Congress 2020. doi:10.1183/13993003.congress-2020.3828 |
 | Poulet, C., NJOCK, M.-S., MOERMANS, C., LOUIS, E., LOUIS, R., MALAISE, M., & GUIOT, J. (01 May 2020). Exosomal Long Non-Coding RNAs in Lung Diseases. International Journal of Molecular Sciences, 21 (10), 3580. doi:10.3390/ijms21103580 Peer Reviewed verified by ORBi |
  | SCHLEICH, F., Graff, S., Nekoee Zahraei, H., MOERMANS, C., HENKET, M., SANCHEZ, C., PAULUS, V., GUISSARD, F., Donneau, A.-F., & Louis, R. (2020). Real-word experience with mepolizumab: Does it deliver what it has promised? Clinical and Experimental Allergy. doi:10.1111/cea.13601 Peer Reviewed verified by ORBi |
 | Guiot, J., HENKET, M., André, B., Herzog, M., Hardat, N., NJOCK, M.-S., MOERMANS, C., Malaise, M., & Louis, R. (2020). A new nucleosomic-based model to identify and diagnose SSc-ILD. Clinical Epigenetics, 12 (1), 124. doi:10.1186/s13148-020-00915-4 Peer Reviewed verified by ORBi |
 | Peerboom, S., Graff, S., SEIDEL, L., PAULUS, V., HENKET, M., SANCHEZ, C., GUISSARD, F., MOERMANS, C., LOUIS, R., & SCHLEICH, F. (2020). Predictors of a good response to inhaled corticosteroids in obesity-associated asthma. Biochemical Pharmacology. doi:10.1016/j.bcp.2020.113994 Peer Reviewed verified by ORBi |
 | MOERMANS, C., Deliege, E., Pirottin, D., Poulet, C., GUIOT, J., HENKET, M., & da Silva, J. (04 December 2019). Suitable reference genes determination for real-time PCR using induced sputum samples. European Respiratory Journal, 54 (6). doi:10.1183/13993003.00644-2018 Peer Reviewed verified by ORBi |
 | BONHOMME, O., ANDRE, B., GESTER, F., DE SENY, D., MOERMANS, C., Struman, I., Louis, R., MALAISE, M., & GUIOT, J. (2019). Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature. Rheumatology. doi:10.1093/rheumatology/kez230 Peer Reviewed verified by ORBi |
 | GUIOT, J., Demarche, S., HENKET, M., PAULUS, V., Graff, S., SCHLEICH, F., Corhay, J.-L., Louis, R., & MOERMANS, C. (2017). Methodology for Sputum Induction and Laboratory Processing. Journal of Visualized Experiments, (130). doi:10.3791/56612 Peer Reviewed verified by ORBi |
 | Fastrès, A., Felice, F., Roels, E., MOERMANS, C., CORHAY, J.-L., Bureau, F., Louis, R., Clercx, C., & GUIOT, J. (16 December 2017). The lung microbiome in idiopathic pulmonary fibrosis: A promising approach for targeted therapies. International Journal of Molecular Sciences, 18 (12), 2735. doi:10.3390/ijms18122735 Peer Reviewed verified by ORBi |
 | Godinas, L., Corhay, J.-L., HENKET, M., GUIOT, J., Louis, R., & MOERMANS, C. (November 2017). Increased production of TGF-β1 from sputum cells of COPD: Relationship with airway obstruction. Cytokine, 99, 1-8. doi:10.1016/j.cyto.2017.06.018 Peer Reviewed verified by ORBi |
 | GUIOT, J., Struman, I., CHAVEZ, V., HENKET, M., Herzog, M., Scoubeau, K., Hardat, N., Bondue, B., Corhay, J.-L., MOERMANS, C., & Louis, R. (15 August 2017). Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis. Clinical Epigenetics, 9, 84. doi:10.1186/s13148-017-0383-x Peer Reviewed verified by ORBi |
 | GUIOT, J., Moermans, C., HENKET, M., Corhay, J.-L., & Louis, R. (2017). Blood Biomarkers in Idiopathic Pulmonary Fibrosis. Lung. doi:10.1007/s00408-017-9993-5 Peer Reviewed verified by ORBi |
 | GUIOT, J., HENKET, M., Corhay, J.-L., Moermans, C., & Louis, R. (08 February 2017). Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7. PLoS ONE, 12 (2), 0171344. doi:10.1371/journal.pone.0171344 Peer Reviewed verified by ORBi |
 | Yanagisawa, H., Hashimoto, M., Minagawa, S., Takasaka, N., Ma, R., MOERMANS, C., Ito, S., Araya, J., Budelsky, A., Goodsell, A., Baron, J. L., & Nishimura, S. L. (2017). Role of IL-17A in murine models of COPD airway disease. American Journal of Physiology - Lung Cellular and Molecular Physiology, 312 (1), 122-L130. doi:10.1152/ajplung.00301.2016 Peer Reviewed verified by ORBi |
 | da Silva, J., Hilzendeger, C., Moermans, C., SCHLEICH, F., HENKET, M., Kebadze, T., Mallia, P., Edwards, I. J., Johnston, S. L., & Louis, R. (2016). Raised interferon beta, type 3 interferon and interferon stimulated genes - evidence of innate immune activation in neutrophilic asthma. Clinical and Experimental Allergy. doi:10.1111/cea.12809 Peer reviewed |
 | Brand, O. J., Somanath, S., Moermans, C., Yanagisawa, H., Hashimoto, M., Cambier, S., Markovics, J., Bondesson, A. J., Hill, A., Jablons, D., Wolters, P., Lou, J., Marks, J. D., Baron, J. L., & Nishimura, S. L. (June 2015). Transforming Growth Factor-beta and Interleukin-1beta Signaling Pathways Converge on the Chemokine CCL20 Promoter. Journal of Biological Chemistry, 290 (23), 14717-28. doi:10.1074/jbc.M114.630368 Peer Reviewed verified by ORBi |
 | Hashimoto, M., Yanagisawa, H., Minagawa, S., Sen, D., Goodsell, A., Ma, R., Moermans, C., McKnelly, K. J., Baron, J. L., Krummel, M. F., & Nishimura, S. L. (2015). A critical role for dendritic cells in the evolution of IL-1beta-mediated murine airway disease. Journal of Immunology, 194 (8), 3962-9. doi:10.4049/jimmunol.1403043 Peer Reviewed verified by ORBi |
 | MOERMANS, C., BONNET, C., WILLEMS, E., Baron, F., NGUYEN DANG, D., HENKET, M., Sele, J., CORHAY, J.-L., Beguin, Y., & Louis, R. (November 2014). Sputum cytokines levels in patients undergoing hematopoietic SCT (HSCT) and comparison with healthy subjects and COPD: a pilot study. Bone Marrow Transplantation, 49 (11), 1382-1388. doi:10.1038/bmt.2014.164 Peer Reviewed verified by ORBi |
 | Corhay, J.-L., MOERMANS, C., HENKET, M., NGUYEN DANG, D., DUYSINX, B., & Louis, R. (28 September 2014). Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD. Respiratory Research, 15, 115. doi:10.1186/s12931-014-0115-0 Peer Reviewed verified by ORBi |
 | MOERMANS, C. (2014). Lung function and airway inflammation monitoring after hematopoietic stem [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/177782 |
 | MOERMANS, C., LECHANTEUR, C., BAUDOUX, E., GIET, O., HENKET, M., SEIDEL, L., LEJEUNE, M., WILLEMS, E., Baron, F., LOUIS, R., & BEGUIN, Y. (2014). Impact of cotransplantation of mesenchymal stem cells on lung function after unrelated allogeneic hematopoietic stem cell transplantation following non-myeloablative conditioning. Transplantation, 98 (3), 348-353. doi:10.1097/TP.0000000000000068 Peer Reviewed verified by ORBi |
 | Moermans, C., Poulet, C., HENKET, M., Bonnet, C., WILLEMS, E., Baron, F., Beguin, Y., & Louis, R. (2013). Lung function and airway inflammation monitoring after hematopoietic stem cell transplantation. Respiratory Medicine, 107, 2071-2080. doi:10.1016/j.rmed.2013.10.013 Peer Reviewed verified by ORBi |
 | MANISE, M., SCHLEICH, F., QUAEDVLIEG, V., Moermans, C., HENKET, M., SELE, J., CORHAY, J.-L., & LOUIS, R. (2012). Disturbed Cytokine Production at the Systemic Level in Difficult-to-Control Atopic Asthma: Evidence for Raised Interleukin-4 and Decreased Interferon-gamma Release following Lipopolysaccharide Stimulation. International Archives of Allergy and Immunology, 158 (1), 1-8. doi:10.1159/000329858 Peer Reviewed verified by ORBi |
 | Moermans, C., HEINEN, V., NGUYEN DANG, D., HENKET, M., SELE, J., Manise, M., Corhay, J.-L., & Louis, R. (2011). Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease. Cytokine, 56 (2), 298-304. doi:10.1016/j.cyto.2011.07.010 Peer Reviewed verified by ORBi |
